HCA Healthcare, Inc. (HCA)
NYSE: HCA · IEX Real-Time Price · USD
319.70
+4.58 (1.45%)
At close: Jul 2, 2024, 4:00 PM
322.00
+2.30 (0.72%)
After-hours: Jul 2, 2024, 7:52 PM EDT
HCA Healthcare Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for HCA Healthcare stock have an average target of 326.18, with a low estimate of 265 and a high estimate of 396. The average target predicts an increase of 2.03% from the current stock price of 319.70.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCA Healthcare stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 6 | 5 | 5 | 5 |
| Buy | 8 | 8 | 7 | 8 | 8 | 8 |
| Hold | 5 | 5 | 5 | 6 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 18 | 19 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $335 | Buy | Reiterates | $335 | +4.79% | Jul 2, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $359 → $375 | Strong Buy | Maintains | $359 → $375 | +17.30% | Jun 28, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $327 → $332 | Hold | Maintains | $327 → $332 | +3.85% | May 30, 2024 |
| Baird | Baird | Buy Initiates $396 | Buy | Initiates | $396 | +23.87% | May 30, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $371 → $360 | Strong Buy | Maintains | $371 → $360 | +12.61% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
70.44B
from 64.97B
Increased by 8.42%
Revenue Next Year
74.22B
from 70.44B
Increased by 5.36%
EPS This Year
21.10
from 18.97
Increased by 11.22%
EPS Next Year
23.46
from 21.10
Increased by 11.19%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 73.9B | 78.8B | 82.9B | 88.7B | 89.6B |
| Avg | 70.4B | 74.2B | 78.1B | 82.5B | 86.2B |
| Low | 67.6B | 70.8B | 74.1B | 78.0B | 83.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.8% | 11.9% | 11.7% | 13.6% | 8.6% |
| Avg | 8.4% | 5.4% | 5.2% | 5.7% | 4.5% |
| Low | 4.0% | 0.5% | -0.1% | -0.1% | 1.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.83 | 26.54 | 32.22 | 32.09 | 32.17 |
| Avg | 21.10 | 23.46 | 26.38 | 29.55 | 30.95 |
| Low | 19.73 | 21.70 | 23.21 | 27.48 | 30.03 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 20.3% | 25.8% | 37.4% | 21.6% | 8.9% |
| Avg | 11.2% | 11.2% | 12.5% | 12.0% | 4.7% |
| Low | 4.0% | 2.8% | -1.1% | 4.2% | 1.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.